Insights

Growth Opportunity Strategic expansion potential through Tessera’s ambitious Gene Writing platforms suggests opportunities to collaborate on drug discovery programs, enabling partnerships with CROs, contract research, and platform integration for joint development.

Financial Scale With revenue in the mid hundreds of millions and substantial funding, Tessera is positioned for collaboration on high-value programs, co-development deals, and platform licensing that align with scalable therapeutic pipelines.

Therapeutic Focus Targeting monogenic diseases, cancer, and autoimmune conditions via genome engineering presents avenues to propose companion diagnostics, translational services, and delivery platform optimization for precision therapies.

Tech Adoption Adoption of diverse tech stacks including OpenAI, cloud hosting, and collaboration tools indicates readiness for digital partnerships, data-driven research collaboration, and integrated digital workflow solutions.

Industry Position Operating among notable CRISPR and gene therapy peers, Tessera can be approached for strategic partnerships on platform benchmarking, joint IP exploration, and collaborative research programs to accelerate market-ready therapies.

Similar companies to Tessera Therapeutics

Tessera Therapeutics Tech Stack

Tessera Therapeutics uses 8 technology products and services including SAP, Adobe Experience Cloud, Microsoft 365, and more. Explore Tessera Therapeutics's tech stack below.

Tessera Therapeutics's Email Address Formats

Tessera Therapeutics uses at least 3 email formats:
Tessera Therapeutics Email FormatsExamplePercentage
FLast@tesseratx.comJDoe@tesseratx.com
80%
First.Last@tesseratx.comJohn.Doe@tesseratx.com
17%
First@tesseratx.comJohn@tesseratx.com
3%

Frequently Asked Questions

What is Tessera Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Tessera Therapeutics's official website is tesseratx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Tessera Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2026, Tessera Therapeutics's annual revenue is estimated to be $100M - $250M.

What is Tessera Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Tessera Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Tessera Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2026, Tessera Therapeutics has approximately 191 employees across 4 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: J. R., Chief Operating Officer: S. M. and Chief Technology Officer: S. T. Explore Tessera Therapeutics's employee directory with LeadIQ.

What industry does Tessera Therapeutics belong to?

Minus sign iconPlus sign icon
Tessera Therapeutics operates in the Biotechnology Research industry.

What technology does Tessera Therapeutics use?

Minus sign iconPlus sign icon
Tessera Therapeutics's tech stack includes SAP, Adobe Experience Cloud, Microsoft 365, Mimecast, OpenAI, DocuSign, Slack and DigitalOcean Web Hosting.

What is Tessera Therapeutics's email format?

Minus sign iconPlus sign icon
Tessera Therapeutics's email format typically follows the pattern of FLast@tesseratx.com. Find more Tessera Therapeutics email formats with LeadIQ.

How much funding has Tessera Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Tessera Therapeutics has raised $773M in funding. The last funding round occurred on Mar 23, 2026 for $41M.
Tessera Therapeutics logo

Tessera Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Tessera Therapeutics is a biotechnology company pursuing genome engineering through its Gene Writing capabilities and delivery platforms, with the aim of unlocking broad therapeutic frontiers. The firm describes its mission as treating disease by editing the genetic code and anticipates that its genetic medicines could address monogenic diseases, cancer, and potentially autoimmune and other conditions.

Based in Somerville, Massachusetts, Tessera operates within the biotechnology research sector as a mid-sized organization focused on advancing genome-writing technologies. Its strategic emphasis covers a broad range of therapeutic areas, signaling an effort to expand treatment options through its platforms.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $773M

    Tessera Therapeutics has raised a total of $773M of funding over 7 rounds. Their latest funding round was raised on Mar 23, 2026 in the amount of $41M as a Grant.

  • $100M - $250M

    Tessera Therapeutics's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.